Can I get Ozempic or Wegovy without insurance?

Yes. Options include Novo Nordisk's NovoCare Patient Assistance Program ($99/month for income-qualified uninsured patients), telehealth subscriptions with compounded semaglutide ($150–$400/month), or the full cash price ($935/month for Ozempic). Most uninsured patients qualify for either the assistance program or a telehealth option.

What income qualifies for Novo Nordisk patient assistance?

NovoCare Patient Assistance Program is generally available to individuals with household incomes at or below 400% of the federal poverty level—roughly $58,000/year for a single person or $120,000 for a family of four in 2025. Income thresholds are updated annually. You must be uninsured or have insurance that doesn't cover the medication.

Are telehealth GLP-1 prescriptions legitimate?

Yes. Telehealth platforms like Ro, Hims/Hers, Henry Meds, and others employ licensed physicians who conduct real clinical evaluations (via video or questionnaire) and issue valid prescriptions. The prescription is sent to a licensed pharmacy (or compounding pharmacy). The clinical standard of care should be equivalent to an in-person visit for most otherwise-healthy patients.

What is the cheapest way to get semaglutide in 2025?

For uninsured income-qualified patients: NovoCare Patient Assistance at $99/month. For those above income limits or those who prefer convenience: telehealth subscriptions with compounded semaglutide starting around $150–$200/month at the initiating dose. Oral semaglutide (Rybelsus) is available for diabetes and sometimes costs less through certain discount programs.

How to Get GLP-1 Medications Without Insurance in 2025

Being uninsured doesn't mean paying list price. Here are the real pathways—with actual costs and eligibility requirements.

Published September 1, 2025 • 10 min read

GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have list prices ranging from $900 to over $1,000 per month. These prices are genuinely prohibitive for most uninsured Americans. But they're also largely theoretical—the realistic cost for most uninsured patients is dramatically lower through a combination of manufacturer assistance, telehealth subscriptions, and compounding.

This guide lays out your real options in 2025, with honest information about eligibility, cost, and what you're actually getting.

Step 1: Determine Whether You Need a Prescription First

All GLP-1 medications—Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Victoza, Trulicity—require a prescription. Before pursuing any cost-reduction strategy, you need a licensed provider to evaluate you and issue a prescription. The good news is that this step is now easier and cheaper than ever, thanks to telehealth.

Use our Eligibility Checker to understand whether you meet the clinical criteria (BMI, comorbidities, diagnosis) before spending time on the access process.

Option 1: Manufacturer Patient Assistance Programs

Both Novo Nordisk (makes Ozempic and Wegovy) and Eli Lilly (makes Mounjaro and Zepbound) operate patient assistance programs for uninsured, income-qualified patients.

NovoCare (Novo Nordisk): Ozempic and Wegovy

The NovoCare Patient Assistance Program provides Ozempic or Wegovy at $99/month for qualifying patients. Requirements:

Must be uninsured (no health insurance at all, or insurance that doesn't cover the medication)
US residency
Income at or below approximately 400% of the federal poverty level (~$58,000/year individual; ~$120,000 for a family of 4 in 2025)
A valid prescription from a US-licensed provider
Completed application with income documentation

The application process takes 2–4 weeks. This is real, brand-name Ozempic/Wegovy—not compounded. If you qualify, this is your best option by far.

Lilly Insulin Value Program / Lilly Cares: Mounjaro and Zepbound

Eli Lilly offers a similar assistance program for Mounjaro (tirzepatide for T2D) and Zepbound (tirzepatide for weight loss). Eligibility and income thresholds are comparable to NovoCare. Qualifying patients receive the medication at reduced cost—check Lilly Cares (lillycares.com) for current program terms and income thresholds, as these change annually.

Important: Both programs require a valid prescription. If you don't have a doctor, telehealth (covered below) is your path to getting one.

Option 2: Telehealth Platforms

Telehealth has transformed GLP-1 access for uninsured and underinsured patients. You can get a clinical evaluation, prescription, and medication delivered to your door—without setting foot in a doctor's office.

How It Works

Complete a health questionnaire online (medical history, current conditions, medications)
A licensed physician reviews your case (video visit or asynchronous review, depending on the platform)
If appropriate, a prescription is issued
Medication is shipped directly (usually compounded semaglutide or tirzepatide)

Major Platforms and Approximate Costs (2025)

Platform	Starting Cost/Month	Notes
Hims & Hers	~$199/mo	Compounded semaglutide; starting dose
Ro (Body)	~$249/mo	Includes provider visits; GLP-1 program
Henry Meds	~$297/mo	Subscription includes ongoing clinical support
Found	~$149–$249/mo	Varies by medication and plan
Calibrate	~$199–$299/mo	Includes metabolic health coaching

Prices vary by dose, platform, and whether medication is included. Always verify current pricing on each platform before signing up.

What These Platforms Typically Prescribe

Most telehealth platforms offering GLP-1s at sub-$300/month are prescribing compounded semaglutide or tirzepatide—not brand-name Ozempic or Wegovy. This is an important distinction. See the compounding section below.

What to Look For in a Telehealth Provider

Licensed physician evaluation (not just a questionnaire with automatic approval)
503B outsourcing facility for the compounded medication (higher quality standards than 503A pharmacies)
Certificate of Analysis (CoA) for each batch—this verifies purity and concentration
Ongoing clinical monitoring (dose adjustments, side effect management)
Clear cancellation policy (subscriptions should be easy to cancel)

Option 3: Compounding Pharmacies (Direct)

Some patients work directly with a compounding pharmacy after getting a prescription from their own doctor or a telehealth provider. This can be lower cost than subscription platforms for the medication itself, but requires more coordination on your end.

As of 2025, the legal landscape around compounded semaglutide has shifted. The FDA removed semaglutide from the drug shortage list in 2025, which changed what 503A compounding pharmacies can legally produce. 503B outsourcing facilities can still produce compounded semaglutide under certain conditions. The situation is complex—read our detailed compounded semaglutide guide for the full picture before going this route.

Option 4: Rybelsus (Oral Semaglutide)

Rybelsus is an oral form of semaglutide, approved for Type 2 diabetes. It's less potent than injectable Ozempic (10mg oral is roughly comparable to 0.5mg injectable in blood sugar effect, though oral bioavailability is limited), but it eliminates the injection barrier for some patients.

Cost without insurance: similar list price to Ozempic (~$900+/month at retail). However, Rybelsus sometimes appears on different formulary tiers and may be accessible through manufacturer savings programs for T2D patients. It's worth asking your pharmacist about current pricing and discount options specifically for Rybelsus if injections are a barrier.

Option 5: International Pharmacy Options

Some patients explore Canadian or other international pharmacies for brand-name semaglutide at lower prices. A few realities:

Technically, personal importation of prescription drugs into the US exists in a legal gray area—FDA generally exercises enforcement discretion for small personal-use quantities
Verified Canadian pharmacies do sell semaglutide at significantly lower prices than US list price
The FDA has not specifically authorized international pharmacy importation for individuals
Quality verification is your responsibility—only use pharmacies verified by PharmacyChecker or CIPA (Canadian International Pharmacy Association)

This is a personal decision involving legal and quality considerations. We're describing what exists, not recommending it.

The Pathway Matrix: What You Should Do Based on Your Situation

Uninsured + income ≤ 400% FPL + Type 2 diabetes or obesity diagnosis:
→ Apply for NovoCare (Ozempic/Wegovy) or Lilly Cares (Mounjaro/Zepbound). $99/month for brand-name medication.

Uninsured + income above 400% FPL, or need access within days not weeks:
→ Telehealth subscription with compounded semaglutide ($150–$300/month). Faster than assistance programs.

Have insurance but it doesn't cover GLP-1s:
→ Novo Nordisk Savings Card may get you to $25/month for Ozempic (requires commercial insurance billing even if it pays nothing). Check your eligibility at novocare.com.

On Medicare, need GLP-1 for weight loss only:
→ Medicare won't cover it. Telehealth subscription with compounded semaglutide or tirzepatide is likely your most accessible option.

Getting the Prescription: Your Options

Regardless of which cost pathway you pursue, you need a prescription. Your options:

Primary care physician: Ideal if you have one. They know your history and can manage your full care. Downside: getting an appointment can take weeks.
Endocrinologist: Specialist in diabetes and metabolic conditions—excellent for complex cases but harder to access quickly.
Telehealth provider: Fastest path, often same-day or next-day. Most telehealth platforms that prescribe GLP-1s will also help you navigate cost (they typically prescribe their own compounded option).
Obesity medicine specialist: If you're pursuing treatment primarily for weight loss, an obesity medicine specialist (find one at the Obesity Medicine Association directory) can provide comprehensive evaluation and help with prior auth if needed.

Use our Cost Calculator to run a personalized estimate of your out-of-pocket cost across these different pathways based on your specific situation.

Frequently Asked Questions

Telehealth platforms are the fastest path—many complete the evaluation and issue a prescription within 24–48 hours, with medication delivered within a week. Manufacturer patient assistance programs take 2–4 weeks for approval. Traditional healthcare appointments for new patients can take weeks to months depending on your location.

Compounded semaglutide contains the same active molecule as Ozempic, but quality can vary depending on the compounding pharmacy. 503B outsourcing facilities have stricter quality standards than 503A pharmacies. When sourced from a reputable facility with current Certificates of Analysis, compounded semaglutide should be clinically equivalent. The FDA has not independently verified individual compounded products, so provider and pharmacy selection matters.

Yes. Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management in adults with a BMI ≥30, or ≥27 with at least one weight-related comorbidity (like hypertension, sleep apnea, or high cholesterol). You don't need a diabetes diagnosis. Telehealth providers can prescribe for these weight management indications.

Very little. GoodRx typically reduces Ozempic's retail price by only $35–$85/month—bringing it from ~$935 to ~$850–$900. GoodRx is effective for generic medications but provides negligible savings on brand-name GLP-1s. Don't rely on it as a primary cost strategy.

Find Your Best GLP-1 Option

Use our tools to compare GLP-1 medications and estimate your realistic cost based on your insurance situation.

Compare GLP-1 Drugs → Cost Calculator →

Medical Disclaimer: This article is for informational purposes only and does not constitute medical or financial advice. Drug prices and program eligibility change frequently. Verify current details directly with manufacturers, telehealth providers, and pharmacies. Consult a licensed healthcare provider before starting any medication.